Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for ARQT

Stock Name	Arcutis Biotherapeutics Inc
Ticker	ARQT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US03969K1088

Show aggregate ARQT holdings

News associated with ARQT

Zurcher Kantonalbank Zurich Cantonalbank Raises Stock Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 3.2% in the first quarter, HoldingsChannel reports. The institutional investor owned 29,697 shares of the company’s stock after purchasing an additional 917 shares during the quarter. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Arcutis Biotherapeutics were worth $464,000 at the […] - 2025-08-08 04:56:49
Arcutis Biotherapeutics (NASDAQ:ARQT) Coverage Initiated at The Goldman Sachs Group: The Goldman Sachs Group began coverage on shares of Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) in a research report released on Friday, MarketBeat.com reports. The brokerage issued a neutral rating and a $18.00 price target on the stock. A number of other brokerages have also commented on ARQT. Needham & Company LLC reiterated a “buy” […] - 2025-07-28 02:05:01
Patrick Burnett Sells 23,000 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock: Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) insider Patrick Burnett sold 23,000 shares of the company’s stock in a transaction on Thursday, July 10th. The stock was sold at an average price of $15.05, for a total value of $346,150.00. Following the sale, the insider owned 115,468 shares of the company’s stock, valued at […] - 2025-07-16 05:29:11
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Receives Consensus Recommendation of “Moderate Buy” from Analysts: Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) have received an average recommendation of “Moderate Buy” from the six brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12 month price […] - 2025-07-10 05:48:58
SG Americas Securities LLC Has $509,000 Stock Position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): SG Americas Securities LLC lowered its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 32.3% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 32,566 shares of the company’s stock after selling 15,521 shares during the period. SG Americas Securities […] - 2025-06-23 04:29:10
Wealth Enhancement Advisory Services LLC Purchases Shares of 20,912 Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Wealth Enhancement Advisory Services LLC purchased a new stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) in the fourth quarter, Holdings Channel.com reports. The institutional investor purchased 20,912 shares of the company’s stock, valued at approximately $291,000. Other hedge funds and other institutional investors have also bought and sold shares of the […] - 2025-06-16 04:08:49
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Boosts Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 1.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 280,100 shares of the company’s stock […] - 2025-06-05 05:16:57
Analysts Anticipate 25% Gains Ahead For The Holdings of FHLC: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-29 08:03:59
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by Deutsche Bank AG: Deutsche Bank AG lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 51.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 387,536 shares of the company’s stock after selling 412,491 shares during the quarter. Deutsche Bank AG’s holdings […] - 2025-05-19 05:07:00
Northern Trust Corp Purchases 54,541 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Northern Trust Corp increased its position in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 5.8% during the fourth quarter, HoldingsChannel reports. The fund owned 991,056 shares of the company’s stock after buying an additional 54,541 shares during the quarter. Northern Trust Corp’s holdings in Arcutis Biotherapeutics were worth $13,805,000 at the end […] - 2025-05-16 04:22:56
Schonfeld Strategic Advisors LLC Sells 7,349 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Schonfeld Strategic Advisors LLC lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 24.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 23,000 shares of the company’s stock after selling 7,349 shares during the quarter. Schonfeld Strategic Advisors […] - 2025-05-13 06:15:01
Price T Rowe Associates Inc. MD Reduces Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Price T Rowe Associates Inc. MD decreased its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 29.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 42,349 shares of the company’s stock after selling 17,799 shares during the […] - 2025-05-13 04:32:49
Voya Investment Management LLC Sells 2,472 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Voya Investment Management LLC trimmed its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 7.1% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 32,136 shares of the company’s stock after selling 2,472 shares during the period. Voya Investment […] - 2025-05-11 05:44:48
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Stock Position Boosted by Tower Research Capital LLC TRC: Tower Research Capital LLC TRC grew its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 62.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 14,231 shares of the company’s stock after buying an additional 5,488 shares during the quarter. […] - 2025-05-06 05:09:04
Wells Fargo & Company MN Has $731,000 Stock Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Wells Fargo & Company MN increased its holdings in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 46.6% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 52,455 shares of the company’s stock after purchasing an additional 16,682 shares during the quarter. Wells Fargo & Company MN’s holdings in Arcutis Biotherapeutics were […] - 2025-05-02 04:18:56
Geode Capital Management LLC Increases Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Geode Capital Management LLC boosted its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 0.1% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 2,472,730 shares of the company’s stock after buying an additional 2,592 shares during the quarter. Geode Capital Management LLC’s holdings in Arcutis Biotherapeutics were worth $34,453,000 as of […] - 2025-04-17 05:18:49
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by Wellington Management Group LLP: Wellington Management Group LLP lowered its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 7.3% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 49,267 shares of the company’s stock after selling 3,882 shares during the quarter. Wellington Management Group LLP’s holdings in Arcutis Biotherapeutics […] - 2025-04-15 04:46:50
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Shares Sold by CIBC Private Wealth Group LLC: CIBC Private Wealth Group LLC reduced its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 18.6% during the 4th quarter, according to its most recent filing with the SEC. The firm owned 7,782 shares of the company’s stock after selling 1,776 shares during the quarter. CIBC Private Wealth Group LLC’s holdings in Arcutis […] - 2025-04-08 06:03:20
Teacher Retirement System of Texas Boosts Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Teacher Retirement System of Texas grew its position in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 19.5% during the 4th quarter, HoldingsChannel reports. The fund owned 31,216 shares of the company’s stock after purchasing an additional 5,087 shares during the period. Teacher Retirement System of Texas’ holdings in Arcutis Biotherapeutics were worth $435,000 at […] - 2025-04-01 04:40:45
Intech Investment Management LLC Buys 5,168 Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Intech Investment Management LLC boosted its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 13.9% during the fourth quarter, Holdings Channel.com reports. The fund owned 42,258 shares of the company’s stock after acquiring an additional 5,168 shares during the period. Intech Investment Management LLC’s holdings in Arcutis Biotherapeutics were worth $589,000 […] - 2025-03-25 06:29:08
AlphaQuest LLC Decreases Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): AlphaQuest LLC lessened its stake in shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 83.3% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 7,142 shares of the company’s stock after selling 35,696 shares during the quarter. AlphaQuest LLC’s holdings in Arcutis Biotherapeutics were worth $99,000 as of its most recent filing […] - 2025-03-19 06:10:46
Bank of New York Mellon Corp Cuts Stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT): Bank of New York Mellon Corp decreased its stake in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) by 1.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 305,007 shares of the company’s stock after selling 6,052 shares during the period. Bank […] - 2025-03-19 05:08:45
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Expected to Rise, Jefferies Financial Group Analyst Says: Arcutis Biotherapeutics (NASDAQ:ARQT – Free Report) had its price target lifted by Jefferies Financial Group from $16.00 to $19.00 in a research report report published on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock. Other research analysts have also issued research reports about the company. HC Wainwright reiterated a “buy” rating […] - 2025-03-12 04:56:51
Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Expected to Rise, Mizuho Analyst Says: Arcutis Biotherapeutics (NASDAQ:ARQT – Get Free Report) had its target price lifted by stock analysts at Mizuho from $20.00 to $21.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Mizuho’s target price suggests a potential upside of 64.06% from the stock’s previous close. A number of […] - 2025-02-28 04:52:44

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc ARQT holdings

Date	Number of ARQT Shares Held	Base Market Value of ARQT Shares	Local Market Value of ARQT Shares	Change in ARQT Shares Held	Change in ARQT Base Value	Current Price per ARQT Share Held	Previous Price per ARQT Share Held
2025-11-12 (Wednesday)	54,977	USD 1,289,211	USD 1,289,211	-181	USD -36,236	USD 23.45	USD 24.03
2025-11-11 (Tuesday)	55,158	USD 1,325,447	USD 1,325,447	0	USD 15,444	USD 24.03	USD 23.75
2025-11-10 (Monday)	55,158	USD 1,310,003	USD 1,310,003	0	USD -26,475	USD 23.75	USD 24.23
2025-11-07 (Friday)	55,158	USD 1,336,478	USD 1,336,478	0	USD -47,988	USD 24.23	USD 25.1
2025-11-06 (Thursday)	55,158	USD 1,384,466	USD 1,384,466	-181	USD 35,301	USD 25.1	USD 24.38
2025-11-05 (Wednesday)	55,339	USD 1,349,165	USD 1,349,165	-1,810	USD -22,982	USD 24.38	USD 24.01
2025-11-04 (Tuesday)	57,149	USD 1,372,147	USD 1,372,147	-362	USD -51,825	USD 24.01	USD 24.76
2025-11-03 (Monday)	57,511	USD 1,423,972	USD 1,423,972	-362	USD -40,794	USD 24.76	USD 25.31
2025-10-31 (Friday)	57,873	USD 1,464,766	USD 1,464,766	0	USD 22,571	USD 25.31	USD 24.92
2025-10-30 (Thursday)	57,873	USD 1,442,195	USD 1,442,195	0	USD -21,413	USD 24.92	USD 25.29
2025-10-29 (Wednesday)	57,873	USD 1,463,608	USD 1,463,608	543	USD 33,224	USD 25.29	USD 24.95
2025-10-28 (Tuesday)	57,330	USD 1,430,384	USD 1,430,384	0	USD 304,423	USD 24.95	USD 19.64
2025-10-27 (Monday)	57,330	USD 1,125,961	USD 1,125,961	0	USD -26,945	USD 19.64	USD 20.11

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of ARQT by Blackrock for IE00B3VWM098

Show aggregate share trades of ARQT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-12 SELL -181 24.350 23.240 23.351 USD -4,227 14.54 Loss of -1,594 on sale
2025-11-06 SELL -181 25.350 23.770 23.928 USD -4,331 14.34 Loss of -1,735 on sale
2025-11-05 SELL -1,810 24.545 23.520 23.623 USD -42,757 14.29 Loss of -16,893 on sale
2025-11-04 SELL -362 24.560 23.850 23.921 USD -8,659 14.24 Loss of -3,505 on sale
2025-11-03 SELL -362 25.430 24.220 24.341 USD -8,811 14.18 Loss of -3,677 on sale
2025-10-29 BUY 543 25.290 25.990 25.920 USD 14,075 14.01
2025-10-24 SELL -181 20.110 20.320 20.299 USD -3,674 13.88 Loss of -1,162 on sale
2025-10-15 BUY 1,086 21.630 21.715 21.707 USD 23,573 13.61
2025-10-02 BUY 181 21.250 21.290 21.286 USD 3,853 13.53
2025-09-30 BUY 362 18.850 19.360 19.309 USD 6,990 13.46
2025-08-21 SELL -181 15.790 15.950 15.934 USD -2,884 13.35 Loss of -467 on sale
2025-07-31 BUY 540 14.580 14.658 14.650 USD 7,911 13.33
2025-06-30 SELL -362 14.020 14.095 14.088 USD -5,100 13.18 Loss of -328 on sale
2025-06-25 SELL -181 14.470 14.648 14.630 USD -2,648 13.16 Loss of -266 on sale
2025-06-20 SELL -362 13.820 14.300 14.252 USD -5,159 13.14 Loss of -404 on sale
2025-05-23 BUY 181 13.980 14.000 13.998 USD 2,534 13.05
2025-05-19 SELL -181 14.640 14.670 14.667 USD -2,655 13.01 Loss of -299 on sale
2025-05-15 SELL -543 13.630 13.781 13.766 USD -7,475 13.00 Loss of -417 on sale
2025-05-12 SELL -181 14.390 14.610 14.588 USD -2,640 12.97 Loss of -292 on sale
2025-05-09 SELL -181 13.530 13.930 13.890 USD -2,514 12.97 Loss of -167 on sale
2025-04-30 SELL -181 14.910 15.000 14.991 USD -2,713 12.86 Loss of -386 on sale
2025-04-24 SELL -362 14.720 14.930 14.909 USD -5,397 12.79 Loss of -768 on sale
2025-04-17 SELL -181 13.010 13.860 13.775 USD -2,493 12.75 Loss of -186 on sale
2025-04-15 SELL -543 13.190 13.670 13.622 USD -7,397 12.74 Loss of -479 on sale
2025-04-14 SELL -543 12.940 13.240 13.210 USD -7,173 12.74 Loss of -256 on sale
2025-04-09 SELL -724 14.570 14.800 14.777 USD -10,699 12.71 Loss of -1,496 on sale
2025-04-07 SELL -1,267 14.300 15.000 14.930 USD -18,916 12.69 Loss of -2,844 on sale
2025-04-04 SELL -1,810 14.730 16.040 15.909 USD -28,795 12.66 Loss of -5,878 on sale
2025-03-31 BUY 181 15.640 16.110 16.063 USD 2,907 12.55
2025-03-19 SELL -362 16.600 16.850 16.825 USD -6,091 12.11 Loss of -1,708 on sale
2025-03-14 SELL -1,086 14.620 15.380 15.304 USD -16,620 11.96 Loss of -3,633 on sale
2025-03-13 SELL -364 14.810 15.400 15.341 USD -5,584 11.92 Loss of -1,246 on sale
2025-03-12 SELL -6,188 15.160 16.090 15.997 USD -98,989 11.87 Loss of -25,535 on sale
2025-03-07 SELL -364 14.720 14.860 14.846 USD -5,404 11.73 Loss of -1,133 on sale
2025-03-06 SELL -546 14.500 15.100 15.040 USD -8,212 11.69 Loss of -1,828 on sale
2025-03-03 SELL -182 12.830 13.850 13.748 USD -2,502 11.60 Loss of -392 on sale
2025-02-28 SELL -1,092 13.690 13.710 13.708 USD -14,969 11.56 Loss of -2,344 on sale
2025-02-26 SELL -182 13.220 13.850 13.787 USD -2,509 11.51 Loss of -414 on sale
2025-02-25 SELL -546 12.200 12.600 12.560 USD -6,858 11.50 Loss of -578 on sale
2025-02-18 BUY 910 12.510 13.620 13.509 USD 12,293 11.37
2025-02-13 BUY 182 12.310 13.220 13.129 USD 2,389 11.30
2025-02-12 BUY 182 13.210 13.880 13.813 USD 2,514 11.26
2025-02-11 BUY 546 11.400 11.485 11.476 USD 6,266 11.26
2025-02-06 BUY 1,638 12.420 13.350 13.257 USD 21,715 11.21
2025-01-27 BUY 182 14.250 15.090 15.006 USD 2,731 10.73
2024-12-30 BUY 910 14.200 14.641 14.597 USD 13,283 10.32
2024-12-06 BUY 724 12.400 12.980 12.922 USD 9,356 10.08
2024-12-05 BUY 181 12.310 12.910 12.850 USD 2,326 10.01
2024-12-04 BUY 905 12.610 12.710 12.700 USD 11,494 9.91
2024-11-29 BUY 905 13.040 13.500 13.454 USD 12,176 9.59
2024-11-27 BUY 724 11.710 11.880 11.863 USD 8,589 9.41
2024-11-26 BUY 181 11.510 11.640 11.627 USD 2,104 9.32
2024-11-25 SELL -12,403 10.770 11.100 11.067 USD -137,264 9.25 Loss of -22,589 on sale
2024-11-21 BUY 1,095 10.240 10.720 10.672 USD 11,686 9.15
2024-11-20 BUY 657 10.180 10.420 10.396 USD 6,830 9.09
2024-11-18 BUY 2,628 9.430 9.460 9.457 USD 24,853 9.01
2024-11-12 BUY 1,744 10.250 10.740 10.691 USD 18,645 8.92
2024-11-08 BUY 1,090 10.820 11.440 11.378 USD 12,402 8.79
2024-11-07 BUY 3,270 10.400 10.780 10.742 USD 35,126 8.66
2024-11-06 BUY 436 9.660 9.900 9.876 USD 4,306 8.58
2024-10-31 BUY 218 8.310 8.520 8.499 USD 1,853 8.49
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-12	SELL	-181	24.350	23.240	23.351	USD -4,227	14.54 Loss of -1,594 on sale
2025-11-06	SELL	-181	25.350	23.770	23.928	USD -4,331	14.34 Loss of -1,735 on sale
2025-11-05	SELL	-1,810	24.545	23.520	23.623	USD -42,757	14.29 Loss of -16,893 on sale
2025-11-04	SELL	-362	24.560	23.850	23.921	USD -8,659	14.24 Loss of -3,505 on sale
2025-11-03	SELL	-362	25.430	24.220	24.341	USD -8,811	14.18 Loss of -3,677 on sale
2025-10-29	BUY	543	25.290	25.990	25.920	USD 14,075	14.01
2025-10-24	SELL	-181	20.110	20.320	20.299	USD -3,674	13.88 Loss of -1,162 on sale
2025-10-15	BUY	1,086	21.630	21.715	21.707	USD 23,573	13.61
2025-10-02	BUY	181	21.250	21.290	21.286	USD 3,853	13.53
2025-09-30	BUY	362	18.850	19.360	19.309	USD 6,990	13.46
2025-08-21	SELL	-181	15.790	15.950	15.934	USD -2,884	13.35 Loss of -467 on sale
2025-07-31	BUY	540	14.580	14.658	14.650	USD 7,911	13.33
2025-06-30	SELL	-362	14.020	14.095	14.088	USD -5,100	13.18 Loss of -328 on sale
2025-06-25	SELL	-181	14.470	14.648	14.630	USD -2,648	13.16 Loss of -266 on sale
2025-06-20	SELL	-362	13.820	14.300	14.252	USD -5,159	13.14 Loss of -404 on sale
2025-05-23	BUY	181	13.980	14.000	13.998	USD 2,534	13.05
2025-05-19	SELL	-181	14.640	14.670	14.667	USD -2,655	13.01 Loss of -299 on sale
2025-05-15	SELL	-543	13.630	13.781	13.766	USD -7,475	13.00 Loss of -417 on sale
2025-05-12	SELL	-181	14.390	14.610	14.588	USD -2,640	12.97 Loss of -292 on sale
2025-05-09	SELL	-181	13.530	13.930	13.890	USD -2,514	12.97 Loss of -167 on sale
2025-04-30	SELL	-181	14.910	15.000	14.991	USD -2,713	12.86 Loss of -386 on sale
2025-04-24	SELL	-362	14.720	14.930	14.909	USD -5,397	12.79 Loss of -768 on sale
2025-04-17	SELL	-181	13.010	13.860	13.775	USD -2,493	12.75 Loss of -186 on sale
2025-04-15	SELL	-543	13.190	13.670	13.622	USD -7,397	12.74 Loss of -479 on sale
2025-04-14	SELL	-543	12.940	13.240	13.210	USD -7,173	12.74 Loss of -256 on sale
2025-04-09	SELL	-724	14.570	14.800	14.777	USD -10,699	12.71 Loss of -1,496 on sale
2025-04-07	SELL	-1,267	14.300	15.000	14.930	USD -18,916	12.69 Loss of -2,844 on sale
2025-04-04	SELL	-1,810	14.730	16.040	15.909	USD -28,795	12.66 Loss of -5,878 on sale
2025-03-31	BUY	181	15.640	16.110	16.063	USD 2,907	12.55
2025-03-19	SELL	-362	16.600	16.850	16.825	USD -6,091	12.11 Loss of -1,708 on sale
2025-03-14	SELL	-1,086	14.620	15.380	15.304	USD -16,620	11.96 Loss of -3,633 on sale
2025-03-13	SELL	-364	14.810	15.400	15.341	USD -5,584	11.92 Loss of -1,246 on sale
2025-03-12	SELL	-6,188	15.160	16.090	15.997	USD -98,989	11.87 Loss of -25,535 on sale
2025-03-07	SELL	-364	14.720	14.860	14.846	USD -5,404	11.73 Loss of -1,133 on sale
2025-03-06	SELL	-546	14.500	15.100	15.040	USD -8,212	11.69 Loss of -1,828 on sale
2025-03-03	SELL	-182	12.830	13.850	13.748	USD -2,502	11.60 Loss of -392 on sale
2025-02-28	SELL	-1,092	13.690	13.710	13.708	USD -14,969	11.56 Loss of -2,344 on sale
2025-02-26	SELL	-182	13.220	13.850	13.787	USD -2,509	11.51 Loss of -414 on sale
2025-02-25	SELL	-546	12.200	12.600	12.560	USD -6,858	11.50 Loss of -578 on sale
2025-02-18	BUY	910	12.510	13.620	13.509	USD 12,293	11.37
2025-02-13	BUY	182	12.310	13.220	13.129	USD 2,389	11.30
2025-02-12	BUY	182	13.210	13.880	13.813	USD 2,514	11.26
2025-02-11	BUY	546	11.400	11.485	11.476	USD 6,266	11.26
2025-02-06	BUY	1,638	12.420	13.350	13.257	USD 21,715	11.21
2025-01-27	BUY	182	14.250	15.090	15.006	USD 2,731	10.73
2024-12-30	BUY	910	14.200	14.641	14.597	USD 13,283	10.32
2024-12-06	BUY	724	12.400	12.980	12.922	USD 9,356	10.08
2024-12-05	BUY	181	12.310	12.910	12.850	USD 2,326	10.01
2024-12-04	BUY	905	12.610	12.710	12.700	USD 11,494	9.91
2024-11-29	BUY	905	13.040	13.500	13.454	USD 12,176	9.59
2024-11-27	BUY	724	11.710	11.880	11.863	USD 8,589	9.41
2024-11-26	BUY	181	11.510	11.640	11.627	USD 2,104	9.32
2024-11-25	SELL	-12,403	10.770	11.100	11.067	USD -137,264	9.25 Loss of -22,589 on sale
2024-11-21	BUY	1,095	10.240	10.720	10.672	USD 11,686	9.15
2024-11-20	BUY	657	10.180	10.420	10.396	USD 6,830	9.09
2024-11-18	BUY	2,628	9.430	9.460	9.457	USD 24,853	9.01
2024-11-12	BUY	1,744	10.250	10.740	10.691	USD 18,645	8.92
2024-11-08	BUY	1,090	10.820	11.440	11.378	USD 12,402	8.79
2024-11-07	BUY	3,270	10.400	10.780	10.742	USD 35,126	8.66
2024-11-06	BUY	436	9.660	9.900	9.876	USD 4,306	8.58
2024-10-31	BUY	218	8.310	8.520	8.499	USD 1,853	8.49

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of ARQT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	341,726	35,090	772,423	44.2%
2025-09-18	165,661	1,522	363,887	45.5%
2025-09-17	284,725	0	630,736	45.1%
2025-09-16	179,844	22	395,466	45.5%
2025-09-15	175,552	0	491,917	35.7%
2025-09-12	307,525	0	657,235	46.8%
2025-09-11	258,316	280	539,943	47.8%
2025-09-10	437,027	1,316	950,925	46.0%
2025-09-09	532,770	0	1,150,718	46.3%
2025-09-08	452,889	5,712	986,459	45.9%
2025-09-05	361,617	50	1,130,359	32.0%
2025-09-04	366,561	100	1,012,477	36.2%
2025-09-03	292,438	175	835,684	35.0%
2025-09-02	228,380	100	443,104	51.5%
2025-08-29	226,806	1,350	420,494	53.9%
2025-08-28	256,315	377	611,736	41.9%
2025-08-27	144,101	0	315,281	45.7%
2025-08-26	209,333	0	530,210	39.5%
2025-08-25	180,217	50	442,972	40.7%
2025-08-22	147,996	0	373,958	39.6%
2025-08-21	89,117	0	274,940	32.4%
2025-08-20	175,749	54	518,920	33.9%
2025-08-19	86,602	0	356,660	24.3%
2025-08-18	152,543	34,957	607,121	25.1%
2025-08-15	136,335	0	738,567	18.5%
2025-08-14	196,629	0	845,242	23.3%
2025-08-13	166,144	452	1,181,490	14.1%
2025-08-12	146,797	0	602,664	24.4%
2025-08-11	270,539	384	620,441	43.6%
2025-08-08	386,298	25,035	1,202,815	32.1%
2025-08-07	1,109,375	22,631	1,675,042	66.2%
2025-08-06	341,028	1,278	574,755	59.3%
2025-08-05	223,064	170	693,798	32.2%
2025-08-04	217,706	41	446,616	48.7%
2025-08-01	401,671	3,150	744,554	53.9%
2025-07-31	177,568	572	398,666	44.5%
2025-07-30	265,582	600	669,791	39.7%
2025-07-29	251,383	2,815	615,844	40.8%
2025-07-28	302,393	0	690,493	43.8%
2025-07-25	450,530	0	755,422	59.6%
2025-07-24	186,949	515	400,240	46.7%
2025-07-23	169,528	0	376,358	45.0%
2025-07-22	284,845	0	536,876	53.1%
2025-07-21	278,122	570	433,724	64.1%
2025-07-18	282,650	0	669,379	42.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE